CBAK ENERGY TECHNOLOGY INC (CBAT)

US14986C1027 - Common Stock

1.04  0 (0%)

After market: 1.06 +0.02 (+1.92%)

Fundamental Rating

3

CBAT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 86 industry peers in the Electrical Equipment industry. CBAT has a bad profitability rating. Also its financial health evaluation is rather negative. CBAT has a correct valuation and a medium growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year CBAT has reported negative net income.
In the past year CBAT had a positive cash flow from operations.
CBAT had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CBAT reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of CBAT (-2.92%) is better than 62.35% of its industry peers.
With a decent Return On Equity value of -7.31%, CBAT is doing good in the industry, outperforming 62.35% of the companies in the same industry.
Industry RankSector Rank
ROA -2.92%
ROE -7.31%
ROIC N/A
ROA(3y)4.7%
ROA(5y)0.26%
ROE(3y)7.75%
ROE(5y)-137.9%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CBAT has a worse Gross Margin (12.52%) than 63.53% of its industry peers.
In the last couple of years the Gross Margin of CBAT has grown nicely.
The Profit Margin and Operating Margin are not available for CBAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.08%
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

CBAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CBAT has been increased compared to 1 year ago.
Compared to 5 years ago, CBAT has more shares outstanding
CBAT has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.29, we must say that CBAT is in the distress zone and has some risk of bankruptcy.
CBAT has a Altman-Z score (0.29) which is in line with its industry peers.
A Debt/Equity ratio of 0.29 indicates that CBAT is not too dependend on debt financing.
CBAT's Debt to Equity ratio of 0.29 is in line compared to the rest of the industry. CBAT outperforms 51.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z 0.29
ROIC/WACCN/A
WACC8.78%

2.3 Liquidity

A Current Ratio of 0.85 indicates that CBAT may have some problems paying its short term obligations.
CBAT's Current ratio of 0.85 is on the low side compared to the rest of the industry. CBAT is outperformed by 94.12% of its industry peers.
A Quick Ratio of 0.61 indicates that CBAT may have some problems paying its short term obligations.
CBAT has a Quick ratio of 0.61. This is amonst the worse of the industry: CBAT underperforms 85.88% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.61

5

3. Growth

3.1 Past

The earnings per share for CBAT have decreased strongly by -200.00% in the last year.
CBAT shows a decrease in Revenue. In the last year, the revenue decreased by -8.71%.
Measured over the past years, CBAT shows a very strong growth in Revenue. The Revenue has been growing by 33.61% on average per year.
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2QN/A
Revenue 1Y (TTM)-8.71%
Revenue growth 3Y123.76%
Revenue growth 5Y33.61%
Revenue growth Q2Q9.91%

3.2 Future

The Earnings Per Share is expected to grow by 47.44% on average over the next years. This is a very strong growth
Based on estimates for the next years, CBAT will show a quite strong growth in Revenue. The Revenue will grow by 12.92% on average per year.
EPS Next Y137.09%
EPS Next 2Y71.09%
EPS Next 3Y47.44%
EPS Next 5YN/A
Revenue Next Year-15.05%
Revenue Next 2Y5.65%
Revenue Next 3Y12.92%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CBAT. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 10.20 indicates a reasonable valuation of CBAT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBAT indicates a rather cheap valuation: CBAT is cheaper than 94.12% of the companies listed in the same industry.
CBAT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.74.
Industry RankSector Rank
PE N/A
Fwd PE 10.2

4.2 Price Multiples

83.53% of the companies in the same industry are more expensive than CBAT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.38

4.3 Compensation for Growth

CBAT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CBAT's earnings are expected to grow with 47.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.09%
EPS Next 3Y47.44%

0

5. Dividend

5.1 Amount

CBAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CBAK ENERGY TECHNOLOGY INC

NASDAQ:CBAT (3/27/2024, 8:04:22 PM)

After market: 1.06 +0.02 (+1.92%)

1.04

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap93.07M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.2
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.92%
ROE -7.31%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 12.52%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.85
Quick Ratio 0.61
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-200%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y137.09%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-8.71%
Revenue growth 3Y123.76%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y